{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:13:21Z","timestamp":1790712801727,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"1186","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Axillary lymph node dissection (ALND) in early breast cancer causes lymphoedema in up to 20% of women and may be unnecessary in those with low axillary disease burden. This study evaluates whether preoperative axillary ultrasound (AUS) can stratify nodal burden to support targeted axillary dissection (TAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective single-centre observational study was conducted using records from January 2023 to December 2024. Among 193 patients with abnormal AUS, those with negative axillary biopsy, neoadjuvant therapy, no surgery, or distant metastases were excluded. Data on AUS findings, tumor size, and postoperative nodal histology were collected. Differences between pN1 (&amp;lt;4 positive nodes on ALND) and pN2-3 (\u22654 positive nodes on ALND) disease were analyzed using non-parametric and categorical tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 193 patients, 142 (73.6%) had positive axillary biopsies; 134 were included. Among these, 76 (56.7%) had 1-2 abnormal nodes on AUS. Of 77 evaluable cases, 33 (42.9%) had pN1 and 44 (57.1%) pN2-3 disease. The mean number of abnormal nodes was higher in pN2-3 (3.05\u2009\u00b1\u20091.85) than pN1 (1.52\u2009\u00b1\u20090.89; P\u2009=\u2009.0001). Tumor size was greater in pN2-3 (57.9\u2009\u00b1\u200933.7\u2009mm) than pN1 (36.5\u2009\u00b1\u200924.3\u2009mm; P\u2009=\u2009.0012). AUS performance: sensitivity 87.1%, specificity 55%, PPV 60%, NPV 84.6%, accuracy 69%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AUS effectively identifies patients with low-volume axillary disease preoperatively and can guide TAD, reducing unnecessary ALND.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Advances in knowledge<\/jats:title>\n                    <jats:p>Preoperative AUS with biopsy predicts low-volume nodal disease with high sensitivity and NPV, enabling accurate triage for TAD and avoiding overtreatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjr\/tqag145","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T16:07:14Z","timestamp":1781021234000},"page":"2178-2186","source":"Crossref","is-referenced-by-count":0,"title":["Less is more: the role of preoperative ultrasound as a risk stratifying tool in identifying low volume axillary disease in breast cancer"],"prefix":"10.1093","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5491-4025","authenticated-orcid":false,"given":"Yasaman","family":"Salari","sequence":"first","affiliation":[{"name":"York and Scarborough Teaching Hospital NHS Foundation Trust Department of Breast Radiology, , York YO31 8HE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavani","family":"Rengabashyam","sequence":"additional","affiliation":[{"name":"York and Scarborough Teaching Hospital NHS Foundation Trust Department of Breast Radiology, , York YO31 8HE,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Shafiei","sequence":"additional","affiliation":[{"name":"University Sussex Hospital NHS Foundation Trust Accident and Emergency Department, , Worthing BN11 2DH,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"2026092915471226500_tqag145-B1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/j.seminoncol.2020.09.001","article-title":"Axillary surgery in breast cancer: an updated historical perspective","volume":"47","author":"Magnoni","year":"2020","journal-title":"Semin Oncol"},{"key":"2026092915471226500_tqag145-B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13193-011-0078-2","article-title":"Complications of axillary lymph node dissection in treatment of early breast cancer: a comparison of MRM and BCS","volume":"2","author":"Brar","year":"2011","journal-title":"Indian J Surg Oncol"},{"key":"2026092915471226500_tqag145-B3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"2026092915471226500_tqag145-B4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026092915471226500_tqag145-B5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of targeted axillary dissection after neoadjuvant therapy in patients with node-positive breast cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"key":"2026092915471226500_tqag145-B6","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"key":"2026092915471226500_tqag145-B7","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1245\/s10434-022-11866-w","article-title":"Preservation of axillary lymph nodes compared with complete dissection in T1-2 breast cancer patients presenting one or two metastatic sentinel lymph nodes: the SINODAR-ONE multicenter randomized clinical trial","volume":"29","author":"Tinterri","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2026092915471226500_tqag145-B8","doi-asserted-by":"publisher","first-page":"101823","DOI":"10.1016\/j.suronc.2022.101823","article-title":"Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer","volume":"44","author":"Arag\u00f3n-S\u00e1nchez","year":"2022","journal-title":"Surg Oncol"},{"key":"2026092915471226500_tqag145-B9","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1245\/s10434-023-13191-2","article-title":"Ten-year oncologic outcomes in T1-3N1 breast cancer after targeted axillary sampling: a retrospective study","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2026092915471226500_tqag145-B10","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/cancers13071539","article-title":"The evolving role of marked lymph node biopsy (MLNB) and targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NACT) for node-positive breast cancer: systematic review and pooled analysis","volume":"13","author":"Swarnkar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026092915471226500_tqag145-B11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/annonc\/mdr355","article-title":"Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the group of surgeons from the French Unicancer Federation","volume":"23","author":"Classe","year":"2012","journal-title":"Ann Oncol"},{"key":"2026092915471226500_tqag145-B12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10549-024-07328-4","article-title":"Current axillary management of patients with early breast cancer and low-volume nodal disease undergoing primary surgery: results of a United Kingdom national practice survey","volume":"206","author":"Fairhurst","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"2026092915471226500_tqag145-B13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ejso.2015.01.011","article-title":"Axillary nodal burden in primary breast cancer patients with positive pre-operative ultrasound guided fine needle aspiration cytology: management in the era of ACOSOG Z011","volume":"41","author":"Boland","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"2026092915471226500_tqag145-B14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-017-4405-3","article-title":"Meta-analysis of tumor burden in pre-operative axillary ultrasound positive and negative breast cancer patients","volume":"166","author":"Ahmed","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"2026092915471226500_tqag145-B15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.crad.2017.12.014","article-title":"Axillary tumor burden in women with one abnormal node on ultrasound compared to women with multiple abnormal nodes","volume":"73","author":"Puri","year":"2018","journal-title":"Clin Radiol"},{"key":"2026092915471226500_tqag145-B16","doi-asserted-by":"publisher","first-page":"P3-08-16","DOI":"10.1158\/1557-3265.SABCS24-P3-08-16","article-title":"Abstract P3-08-16: TADPOLE: a multicentre, pragmatic, phase III randomised controlled trial comparing targeted axillary dissection vs axillary node clearance in patients with POsitive axillary lymph nodes in early breast cancer","volume":"31","author":"Potter","year":"2025","journal-title":"Clin Cancer Res"},{"key":"2026092915471226500_tqag145-B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-022-06672-7","article-title":"Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis","volume":"195","author":"Ngai","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"2026092915471226500_tqag145-B18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"2026092915471226500_tqag145-B19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4048\/jbc.2019.22.e8","article-title":"Determining whether high nodal burden in early breast cancer patients can be predicted preoperatively to avoid sentinel lymph node biopsy","volume":"22","author":"Lim","year":"2019","journal-title":"J Breast Cancer"},{"key":"2026092915471226500_tqag145-B20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.suronc.2020.08.020","article-title":"Ultrasound staging in breast cancer: a decision-making oriented approach to axillary metastatic burden prediction","volume":"35","author":"G\u00e1lvez","year":"2020","journal-title":"Surg Oncol"},{"key":"2026092915471226500_tqag145-B21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.breast.2012.09.003","article-title":"Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice","volume":"22","author":"Yoshihara","year":"2013","journal-title":"Breast"},{"key":"2026092915471226500_tqag145-B22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4048\/jbc.2021.24.e4","article-title":"Relation between tumor size and lymph node metastasis according to subtypes of breast cancer","volume":"24","author":"Min","year":"2021","journal-title":"J Breast Cancer"},{"key":"2026092915471226500_tqag145-B23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1245\/s10434-022-12203-x","article-title":"Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2026092915471226500_tqag145-B24","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","article-title":"The relationship between tumor size, nodal status and distant metastases: on the origins of breast cancer","volume":"170","author":"Sopik","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"2026092915471226500_tqag145-B25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/njs.NJS_47_19","article-title":"A study correlating the tumor site and size with the level of axillary lymph node involvement in breast cancer","volume":"26","author":"Chand","year":"2020","journal-title":"Niger J Surg"},{"key":"2026092915471226500_tqag145-B26","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.1038\/s41598-024-84115-7","article-title":"Tumor characteristics and survival rate of axillary metastatic breast cancer patients: a three decades retrospective cohort study","volume":"15","author":"Mousavi-Kiasary","year":"2025","journal-title":"Sci Rep"},{"key":"2026092915471226500_tqag145-B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40644-019-0191-y","article-title":"Prediction of high nodal burden with ultrasound and magnetic resonance imaging in clinically node-negative breast cancer patients","volume":"19","author":"Kim","year":"2019","journal-title":"Cancer Imaging"},{"key":"2026092915471226500_tqag145-B28","author":"Sharma","year":"2023"},{"key":"2026092915471226500_tqag145-B29","volume-title":"Guidance on Screening and Symptomatic Breast Imaging","year":"2019","edition":". 4th ed."},{"key":"2026092915471226500_tqag145-B30","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/bjs.10661","article-title":"Axillary tumor burden in women with a fine-needle aspiration\/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node","volume":"104","author":"Lloyd","year":"2017","journal-title":"Br J Surg"},{"key":"2026092915471226500_tqag145-B31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.crad.2017.11.023","article-title":"Does preoperative axillary staging lead to overtreatment of women with screen-detected breast cancer?","volume":"73","author":"Wallis","year":"2018","journal-title":"Clin Radiol"},{"key":"2026092915471226500_tqag145-B32","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1245\/s10434-017-5935-y","article-title":"Positive ultrasound-guided lymph node needle biopsy in breast cancer may not mandate axillary lymph node dissection","volume":"24","author":"Harris","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2026092915471226500_tqag145-B33","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"key":"2026092915471226500_tqag145-B34","doi-asserted-by":"publisher","first-page":"TPS615","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS615","article-title":"ATNEC: a multicenter, randomized trial investigating whether axillary treatment can be avoided in patients with T1-3N1M0 breast cancer with no residual cancer in the lymph glands after neoadjuvant chemotherapy","volume":"40","author":"Goyal","year":"2022","journal-title":"JCO"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqag145\/68495408\/tqag145.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2178\/68495408\/tqag145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2178\/68495408\/tqag145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:47:19Z","timestamp":1790711239000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/99\/1186\/2178\/8704547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":34,"journal-issue":{"issue":"1186","published-online":{"date-parts":[[2026,6,9]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqag145","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,6,9]]}}}